Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1997-12-23
1999-09-07
Tsang, Cecilia J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 9, 530317, 530321, A61K 3702, C07K 764
Patent
active
059487550
ABSTRACT:
The cyclosporin compound of formula (I) is particularly useful in the treatment and/or prophylaxis of retrovirus infections. ##STR1##
REFERENCES:
patent: 4703033 (1987-10-01), Seebach
patent: 4771122 (1988-09-01), Seebach
patent: 4814323 (1989-03-01), Andrieu et al.
Papageorgiou et al., "Anti HIV-1 Activity of a Hydrophilic Cyclosporin Derivative With Improved Binding Affinity to Cyclophilin A," Bioorganic & Medicinal Chemistry Letters, 6(1):23-26 (1996).
Mikol et al., "The Role of Water Molecules in the Structure-Based Design of (5-Hydroxynorvaline)-2-cyclosporin: Synthesis, Biological Activity, and Crystallographic Analysis With Cyclophilin A," J. Med. Chem., 38(17):3361-3367 (1995).
Billich et al., "Mode of Action of SDZ NIM 811, a Nonimmunosuppressive Cyclosporin A Analog with Activity Against Human Immunodeficiency Virus (HIV) Type 1: Interference with HIV Protein Cyclophilin A Interactions," J. of Virology, 69(4):2451-2461, (1995).
Barriere Jean-Claude
Bashiardes Georges
Carry Jean-Christophe
Evers Michel
Filoche Bruno
Rhone-Poulenc Rorer S.A.
Tsang Cecilia J.
LandOfFree
Cyclosporin compound, its preparation and the pharmaceutical com does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cyclosporin compound, its preparation and the pharmaceutical com, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cyclosporin compound, its preparation and the pharmaceutical com will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1804575